- Home
- TIL vs PCF Comparison
TIL vs PCF Comparison
Compare TIL & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- PCF
- Stock Information
- Founded
- TIL 2018
- PCF 1987
- Country
- TIL United States
- PCF United States
- Employees
- TIL N/A
- PCF N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- PCF Trusts Except Educational Religious and Charitable
- Sector
- TIL Health Care
- PCF Finance
- Exchange
- TIL Nasdaq
- PCF Nasdaq
- Market Cap
- TIL 171.7M
- PCF 196.9M
- IPO Year
- TIL 2021
- PCF N/A
- Fundamental
- Price
- TIL $17.21
- PCF $6.61
- Analyst Decision
- TIL Buy
- PCF
- Analyst Count
- TIL 5
- PCF 0
- Target Price
- TIL $114.00
- PCF N/A
- AVG Volume (30 Days)
- TIL 85.6K
- PCF 74.8K
- Earning Date
- TIL 03-04-2025
- PCF 01-01-0001
- Dividend Yield
- TIL N/A
- PCF 10.90%
- EPS Growth
- TIL N/A
- PCF N/A
- EPS
- TIL N/A
- PCF N/A
- Revenue
- TIL N/A
- PCF N/A
- Revenue This Year
- TIL N/A
- PCF N/A
- Revenue Next Year
- TIL N/A
- PCF N/A
- P/E Ratio
- TIL N/A
- PCF N/A
- Revenue Growth
- TIL N/A
- PCF N/A
- 52 Week Low
- TIL $9.62
- PCF $5.71
- 52 Week High
- TIL $92.00
- PCF $6.96
- Technical
- Relative Strength Index (RSI)
- TIL 42.69
- PCF 42.81
- Support Level
- TIL $17.87
- PCF $6.60
- Resistance Level
- TIL $19.61
- PCF $6.68
- Average True Range (ATR)
- TIL 1.68
- PCF 0.07
- MACD
- TIL -0.06
- PCF -0.01
- Stochastic Oscillator
- TIL 5.69
- PCF 41.33
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.